Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | IDUA | P35475 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18911637 | 1.00 | SUCNR1 (0.39) | SUCNR1THRBLMNATDP1IDUA | |
| SCHEMBL12346259 | 1.00 | SUCNR1 (0.39) | SUCNR1THRBLMNATDP1IDUA | |
| SCHEMBL1669031 | 1.00 | SUCNR1 (0.39) | SUCNR1THRBLMNATDP1IDUA | |
| SCHEMBL24212766 | 1.00 | SUCNR1 (0.39) | SUCNR1THRBLMNATDP1IDUA | |
| SCHEMBL4267050 | 1.00 | SUCNR1 (0.39) | SUCNR1THRBLMNATDP1IDUA | |
| SCHEMBL23720424 | 1.00 | SUCNR1 (0.39) | SUCNR1THRBLMNATDP1IDUA | |
| SCHEMBL13792996 | 1.00 | SUCNR1 (0.39) | SUCNR1THRBLMNATDP1IDUA | |
| SCHEMBL15061094 | 1.00 | SUCNR1 (0.39) | SUCNR1THRBLMNATDP1IDUA | |
| SCHEMBL21097517 | 1.00 | SUCNR1 (0.39) | SUCNR1THRBLMNATDP1IDUA | |
| SCHEMBL17828572 | 1.00 | SUCNR1 (0.39) | SUCNR1THRBLMNATDP1IDUA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090280074-A1 | USE OF GLYCYRRHETIC ACID AND/OR GLYCYRRHIZIN FOR PRODUCING COSMETIC PREPARATIONS FOR TANNING THE SKIN | BEIERSDORF AG (DE) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090280074-A1 | USE OF GLYCYRRHETIC ACID AND/OR GLYCYRRHIZIN FOR PRODUCING COSMETIC PREPARATIONS FOR TANNING THE SKIN | CUTA, TYR, MC1R | SUCNR1 81/4885THRB 3273/4885LMNA 2080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.